Is HEXO a Buy Under $2?

: HEXO | HEXO Corp. News, Ratings, and Charts

HEXO – Canada-based cannabis company HEXO’s (HEXO) shares have declined in price over the past few months to their $1.60 all-time low yesterday. But can the stock rebound on the back of the promising Canadian cannabis industry? Read on.

Headquartered in Kanata, Canada, consumer packaged goods cannabis company HEXO Corp. (HEXO) produces and distributes innovative products to serve the global cannabis market. Canada legalized cannabis in 2018, and Canada’s legal adult-use cannabis market is expected to reach CAD8.62 billion ($6.97 billion) by 2026. However, the industry continues to face several restrictions.

HEXO’s shares have declined 14.5% in price over the past month and 61.5% over the past three months to close yesterday’s trading session at $1.65, after hitting its all-time low of $1.60.

Scott Cooper was appointed as the company’s new President & CEO on October 20 after its former co-founded, CEO Sebastien St-Louis, left due to a ‘strategic reorganization.’ Also, HEXO has remained unprofitable in the third quarter, and its EPS is expected to remain negative in its fiscal fourth quarter (ended July 31, 2021). So, HEXO’s near-term prospects look bleak.

Click here to check out our Cannabis Industry Report for 2021

Here are the factors that could influence HEXO’s performance in the upcoming months:

Cash Outflow for Acquisitions

HEXO acquired 48North Cannabis Corp. on September 1. On August 30, it acquired Redecan, Canada’s largest privately-owned licensed producer, for $400 million in cash and 69.70 million newly issued common shares of HEXO. Also, on June 1, HEXO acquired Zenabis Global Inc. It has made several other acquisitions over the past years, without much success; Its persistent cash outflow for acquisitions could take a toll on its already weak financials.

Unimpressive Financials

For its fiscal third quarter, ended April 30, 2021, HEXO’s net revenue decreased 31.1% sequentially to CAD22.66 million ($18.33 million). The company’s revenue from non-beverage adult-use fell 29% sequentially, due primarily to a sequential sales decline in the province of Quebec and certain production decisions. Its net loss came in at CAD20.71 million ($16.76 million), up 6.1% year-over-year. And its loss per share was CAD0.17, versus CAD0.26 in the year-ago period.

Poor Profitability

In terms of trailing-12-month gross profit margin, HEXO’s 9.72% is 82.3% lower than the 54.88% industry average. The stock’s 0.17% trailing-12-month asset turnover ratio is 52.9% lower than the 0.35% industry average. Furthermore, its trailing-12-month EBIT and EBITDA margins are negative, compared to the2.14% and 5.70% respective industry averages.

POWR Ratings Reflect Bleak Prospects

HEXO has an overall rating of F, which equates to a Strong Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree. 

Our proprietary rating system also evaluates each stock based on eight distinct categories. HEXO has a D grade for Momentum, which is in sync with its 14.5% loss over the past month and 74.9% decline over the past six months.

The stock has an F grade for Quality, which is consistent with its lower-than-industry profitability ratios. HEXO’s 2.15 beta helped it earn an F grade for Stability.

Moreover, the stock has an F grade for Sentiment because analysts expect HEXO’s EPS to remain negative this year and next year.

HEXO is ranked #196 out of 202 stocks in the Medical – Pharmaceuticals industry. In addition to the POWR Rating grades I have just highlighted, we’ve also rated HEXO for Growth and Value. Click here to get all HEXO’s ratings.

Click here to checkout our Healthcare Sector Report for 2021

Bottom Line

HEXO is a low-priced stock, but we think it could be wise to avoid the stock now, given the company’s weak financials. Moreover, analysts expect its EPS to remain negative in the coming quarters.

How Does HEXO (HEXO) Stack Up Against its Peers?

While HEXO has an overall F POWR Rating, one  might want to consider taking a look at its industry peers having an A (Strong Buy) rating, such as Johnson & Johnson (JNJ), Novartis AG (NVS), and GlaxoSmithKline plc (GSK).

Click here to check out our Cannabis Industry Report for 2021


HEXO shares fell $1.65 (-100.00%) in premarket trading Friday. Year-to-date, HEXO has declined -55.16%, versus a 23.78% rise in the benchmark S&P 500 index during the same period.


About the Author: Manisha Chatterjee


Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
HEXOGet RatingGet RatingGet Rating
JNJGet RatingGet RatingGet Rating
NVSGet RatingGet RatingGet Rating
GSKGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Recession is Here...Watch Out Below!

More and more it looks like recession is here. This includes a dramatic decline for ISM Manufacturing discovered this morning. As you likely know, most economist call manufacturing the "canary in the coal mine" for the US economy as it often shows weakness before other areas. In fact, GDP Now from the Atlanta Fed reads it loud and clear with a negative revision for the US economy down to -2.1% for Q2. Ouch! We are going to discuss these new economic facts...what it means for the stock market outlook...and an interesting view on why the S&P 500 (SPY) does not decline in orderly fashion. All that and more is coming your way in this week's commentary…

:  |  News, Ratings, and Charts

4 Ideal Stocks to Add to Your Portfolio in July

While sluggish consumer spending data led to the stock market ending the last trading session of June in the red, a moderate inflation forecast is nurturing hopes over the economy to avoid a recession. Therefore, investors might consider buying quality stocks ARC Document Solutions (ARC), Core Molding Technologies (CMT), DLH Holdings (DLHC), and Friedman Industries (FRD) at their current low price levels to benefit from their big rebounds. Read more…

:  |  News, Ratings, and Charts

Stocks to Fall MUCH FURTHER this Bear Market Cycle

Spoiler alert...the bear market is not over. Unfortunately history shows that the S&P 500 (SPY) has much further to fall to squeeze out excess valuation. That is just a natural part of the bear market process that is properly explained in this timely market commentary. More importantly, this commentary provides a strategy on how to profit in the days and weeks ahead as the market finds its way to bottom. Read on below for more...

:  |  News, Ratings, and Charts

Wall Street Analysts Predict More Than 160% Upside in These Stocks

The high global inflation and hawkish federal reserve are leading to heightened volatility in the market. However, despite the market uncertainties, Wall Street analysts see a more than 160% upside potential in IonQ (IONQ) and Rigetti Computing (RGTI). Thus, these stocks could be ideal additions to your watchlist. Keep reading…

:  |  News, Ratings, and Charts

Stocks to Fall MUCH FURTHER this Bear Market Cycle

Spoiler alert...the bear market is not over. Unfortunately history shows that the S&P 500 (SPY) has much further to fall to squeeze out excess valuation. That is just a natural part of the bear market process that is properly explained in this timely market commentary. More importantly, this commentary provides a strategy on how to profit in the days and weeks ahead as the market finds its way to bottom. Read on below for more...

Read More Stories

More HEXO Corp. (HEXO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All HEXO News